![glp 1 summit 2nd GLP-1-Based Therapeutics 2025 [04/29/25] glp 1 summit What an](https://media.thebostoncalendar.com/images/q_auto,fl_lossy/v1738219627/pjmw3upta2sablq6vpmq/2nd-glp-1-based-therapeutics-summit-2025.jpg)
glp 1 summit 2nd GLP-1-Based Therapeutics 2025 [04/29/25] glp 1 summit What an
Description
"Stopping weight loss drugs can feel like jumping off a cliff The food noise comes back as quickly as the next day." Dr
![glp 1 summit 2nd GLP-1-Based Therapeutics 2025 [04/29/25] glp 1 summit What an](https://lookaside.fbsbx.com/lookaside/crawler/media/?media_id=1759521528402376)
Patient Type Analysis The anti-obesity drugs market is predominantly driven by adult patients contributing 95.3% share in 2024, reflecting the high prevalence of obesity in this demographic
![glp 1 summit 2nd GLP-1-Based Therapeutics 2025 [04/29/25] glp 1 summit What an](https://assets1.progressivegrocer.com/images/v/max_width_1440/files/2026-07/inline_story_image_glp1_shopper_summit_1.jpg)
But they are also common, medically explainable and not a sign that something is wrong
![glp 1 summit 2nd GLP-1-Based Therapeutics 2025 [04/29/25] glp 1 summit What an](https://www.americanconference.com/glp-1-law-policy/wp-content/uploads/sites/2215/2026/03/140L25_LinkedIn_General_1200x1200.png)
For DTP teams: this changes the eligibility messaging materially
![glp 1 summit 2nd GLP-1-Based Therapeutics 2025 [04/29/25] glp 1 summit What an](https://smtpeptides.com/wp-content/uploads/2026/04/smt-peptides-semaglutide-20mg-scaled.png)
Clinical response: Review dosage and consider slowing titration
![glp 1 summit 2nd GLP-1-Based Therapeutics 2025 [04/29/25] glp 1 summit What an](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3886878430339812179)
